Onderneming PURE Bioscience OTC Bulletin Board
Aandelen
US74621T2096
Huishoudelijke producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pure Hard Surface
95,2
%
| 1 | 80,8 % | 2 | 95,2 % | +19,23% |
Silverion
4,5
%
| 0 | 17,0 % | 0 | 4,5 % | -73,02% |
Royalty
0,3
%
| 0 | 2,2 % | 0 | 0,3 % | -85,00% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | +1,30% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08-02-23 |
Mark Elliott
DFI | Director of Finance/CFO | 48 | 01-01-04 |
Dolana Blount
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-98 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 09-05-11 |
Tom Lee
BRD | Director/Board Member | 75 | 24-10-14 |
John Kasperski
SAM | Sales & Marketing | - | 01-04-22 |
Zhinong Yan
PRN | Corporate Officer/Principal | - | 01-05-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08-02-23 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 09-05-11 |
Tom Lee
BRD | Director/Board Member | 75 | 24-10-14 |
Ivan Chen
CHM | Chairman | 41 | 28-06-18 |
David Rendall
BRD | Director/Board Member | 51 | 27-01-21 |
Bernard Blotner
BRD | Director/Board Member | 73 | 08-02-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 111 856 473 | 66 608 477 ( 59,55 %) | 0 | 59,55 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,51% | 25,78 mld. | |
-6,34% | 16,59 mld. | |
-15,86% | 6,91 mld. | |
+2,65% | 5,79 mld. | |
-8,87% | 2,95 mld. | |
-2,71% | 2,17 mld. | |
-0,11% | 2,1 mld. | |
+19,54% | 888 mln. | |
+5,80% | 657 mln. |